SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Any info about Iomega (IOM)?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Coley who wrote (48328)2/20/1998 12:36:00 PM
From: Rocky Reid  Read Replies (1) of 58324
 
OFF TOPIC- QGLY

I'm holding onto my QGLY no matter what. Check out this write-up from The Motley Fool:

fnews.yahoo.com

Once just the little company that could, Quigley Corp. (Nasdaq:QGLY - news) , the maker of the popular zinc gluconate-glycine lozenges marketed as Cold-Eeze, is fast becoming the little company that both has and perhaps will. Since the Federal Reserve pronounced the stock marginable on February 9 and presumably enticed some previously hesitant investors to jump in, Quigley's stock has bounced from $12 a share to yesterday's close of $15 3/16, a gain of 27%.

The rally picked up steam yesterday when the stock rose $2 1/8 following the company's announcement of a Canadian distribution deal with Genpharm Inc., a subsidiary of the $5 billion German pharmaceutical firm Merck KGaA. This agreement is Quigley's first venture outside the U.S. and a launch in the United Kingdom is expected shortly. Such international distribution deals mark the next chapter in a remarkable growth story that continues to surprise skeptics...Gross Margins 70%, Net Margins 30%...
(it goes on)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext